Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

ACTAVIS INC
Mes dernières consult.
Most popular
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ACTAVIS INC
05/13 High-profile Snap stakeholders revealed in filings
05/13 High-profile Snap stakeholders revealed in filings
05/09DJALLERGAN : Thin Is In as Allergan Dodges Generics Bullet -- Heard on the Street
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/03DJPerrigo Says Investigators Searched Its Offices in Generic-Drug Probe
02/24 ALLERGAN PLC : ex-dividend day
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/13 Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
02/13 Stada to hold takeover talks with rival suitors Cinven and Advent
02/13DJALLERGAN : to Buy Fat Treatment Maker Zeltiq for $2.3 Billion
02/08 Allergan says U.S. tax reform unlikely in 2017, sees strong year
02/08DJALLERGAN : Results Boosted by New, Established Drugs -- Update
02/08DJALLERGAN : Results Boosted by New, Established Drugs
01/24 U.S. reaches settlement with Endo on pay-for-delay charges
01/18DJAllergan Admits to Disclosure Violations During Valeant Bid
01/17 Allergan to pay $15 million over failing to disclose merger talks
01/10DJValeant Agrees To Sell Dendreon -- WSJ
01/03DJAfter Slower Year, Deal Prospects Set to Brighten -- WSJ
2016 Actavis UK raised drug prices 12,000 percent, watchdog finds
2016 U.S. states sue Mylan, Teva, others for fixing drug prices
2016DJMARKET SNAPSHOT : S&P 500, Dow Hit Intraday Records, On Track For Weekly Gains
2016DJCorrection to Novo Nordisk Pledges to Limit Price Increases in US for Its Dru..
2016DJNovo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs
2016DJNovo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs
2016 Pharma execs weigh in on possible changes under Trump
2016DJValeant's Discussions to Sell Salix to Takeda Have Broken Down
2016 Lilly's drug for Alzheimer's fails big trial; shares drop
2016 Teva trims 2016 outlook on drug launch delays
2016DJTEVA PHARMACEUTICAL INDUSTRIES : Revenue Rises on Allergan Deal -- Update
2016DJTeva Revenue Rises on Allergan Deal
2016DJGeneric Drug Firms Face Possible Collusion Charges -- WSJ
2016 Drugmakers under fire for possible U.S. price fixing
2016DJGeneric-Drug Firms Face Possible Collusion Charges -- 1st update
2016DJGeneric-Drug Makers' Shares Drop on Report of Possible Probe
2016 Allergan CEO takes blame for big miss on quarterly earnings
2016DJU.S. HOT STOCKS : Hot Stocks to Watch
2016DJALLERGAN : Initiates Dividend, Expands Buyback
2016DJValeant, Saddled With Debt, in Talks to Sell Big Drug Line
2016DJPFIZER : Cuts Outlook, Ends Development of Cholesterol Drug
2016ALLERGAN PLC : quaterly earnings release
2016DJPAUL BISARO : Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman
2016DJMONEYBEAT : Banner M&A Week Despite Election -- WSJ
2016 U.S. targets corporate tax-reduction strategy with new regulation
2016DJPfizer Loses UK Appeal Court Patent Case Over Lyrica
2016 Teva to sell Allergan's generics business in UK, Ireland for $769 million
2016DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Actavis Generics European Assets to Accor..
2016DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Actavis Generics European Assets to Accor..
2016 AstraZeneca licenses respiratory drug to Insmed
2016DJASTRAZENECA : Signs Deal with Allergan for Up To $1.52 Billion
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016DJAllergan to Buy Vitae Pharmaceuticals for $639 Million
2016 BAYER EXPLORING SALE OF DERMATOLOGY : Bloomberg
2016 EXCLUSIVE - GW PHARMACEUTICALS HIRES : sources
2016 U.S. slams EU, but Apple tax demand first issued in Washington
2016DJMondelez Walks Away After Hershey Spurns Raised Bid
2016DJPfizer Buys Part of AstraZeneca's Antibiotics Business
2016DJBotox Maker Allergan's Revenue Climbs, but Loss More Than Doubles -- WSJ
2016DJAllergan Revenue Increases, Though Loss Widens--Update
2016DJMARKET SNAPSHOT : Stocks Back Off All-time Highs As Health-care Stocks Slump
2016DJMARKET SNAPSHOT : Stocks Retreat From Records As Health-care Stocks Slump
2016DJU.S. Stocks Slip Despite Surge in Energy Sector
2016DJPFIZER : Business Groups Sue Over Inversion Rules -- WSJ
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Upd..
2016 Business groups sue over new U.S. limit on tax-driven foreign buyouts
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules -- Update
2016DJPFIZER : Business Groups Sue U.S. Government Over Tax-Inversion Rules
2016DJPFIZER : U.S. Government Sued Over Tax-Inversion Rules
2016 Teva Pharm eyes more acquisitions after buying Allergan's generics business
2016DJTEVA PHARMACEUTICAL : Profit Falls on Write-Downs
2016DJTEVA PHARMACEUTICAL : Business Watch -- WSJ
2016 Allergan to sell Anda drug distribution business to Teva
2016ALLERGAN PLC : half-yearly earnings release
2016DJTEVA PHARMACEUTICAL : to Buy Generics Distributor Anda From Allergan for $500 Mi..
2016DJTEVA PHARMACEUTICAL : to Buy Generics Distributor Anda From Allergan for $500 Mi..
2016DJPFIZER : Hit As Sales Of Older Drugs Fall -- WSJ
Prev.1   2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 15 924 M
EBIT 2017 7 642 M
Net income 2017 -3 114 M
Debt 2017 24 449 M
Yield 2017 1,31%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 6,23x
EV / Sales 2018 5,74x
Capitalization 74 801 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 266 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC74 801
JOHNSON & JOHNSON15.83%358 180
NOVARTIS7.89%216 850
ROCHE HOLDING LTD.3.78%215 061
PFIZER2.06%195 090
MERCK AND COMPANY6.03%169 014